참고문헌
- Ayer, D. E. 1999. Histone deacetylase: Transcriptional repression with SINers and NuRDs. Trends in Cell Biol. 9: 193-198
- Darkin-Rattray, S., A. M. Gurnett, R. W. Myres, P. M. Dulski, K. M. Crumely, J. J. Allocco, C. Cannova, P. T. Meinke, S. L. Colletti, M. A. Bednarek, S. B. Singh, M. A. Goetz, A. W. Dombrowski, J. D. Polishook, and D. M. Schimatz. 1996. Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase. Proc. Natl. Acad. Sci. USA 93: 13143-13147
- Field, S. and O. Song. 1989. A novel genetic system to detect protein-protein interactions. Nature 340: 245-247
- Grunstein, M. 1997. Histone acetylation in chromatin structure and transcription. Nature 389: 349-352 https://doi.org/10.1038/38664
- Guschin, D., P. A. Wade, N. Kikyo, and A. P. Wolffe. 2000. ATP-Dependent histone octamer mobilization and histone deacetylation mediated by the Mi-2 chromatin remodeling complex. Biochemistry 39: 5238-5245
- Hassig, C. A., T. C. Fleischer, A. N. Billin, S. L. Schreiber, and D. E. Ayer. 1997. Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 89: 341- 347
- Itazaki, H., K. Nagashima, K. Sugita, H. Yoshida, Y. Kawamura, Y. Yasuda, K. Matsumoto, K. Ishii, N. Uotani, H. Kakai, A. Terui, S. Yoshimatsu, Y. Ikenishi, and Y. Nakagawa. 1990. Isolation and structural elucidation of new cyclotetrapeptides, trapoxins A and B, having detransformaiton activities as antitumor agents. J. Antibiot. 43: 1524-1532
- Juan, L. J., W. J. Shia, M. H. Chen, W. M. Yang, E. Seto, Y. S. Lin, and C. W. Wu. 2000. Histone deacetylases specifically down-regulate p53-dependent gene activation. J. Biol. Chem. 275: 20436-20443
- Kang, J., T. Kim, Y. G. Ko, S. B. Rho, S. G. Park, M. J. Kim, H. J. Kwon, and S. Kim. 2000. Heat shock protein 90 mediates protein-protein interactions between human aminoacyl-tRNA synthetases. J. Biol. Chem. 275: 31682- 31688 https://doi.org/10.1074/jbc.M909965199
- Keegan, L., G. Gill, and M. Ptashne. 1996. Separation of DNA binding from the transcription-activating function of a eukaryotic regulatory protein. Science 231: 699-704
- Ki, S. W., K. Kasahara, H. J. Kwon, J. Eishima, K. Takesako, J. A. Cooper, M. Yoshida, and S. Horinouchi. 1998. Identification of radicicol as an inhibitor of in vivo Ras/Raf interaction with the yeast two-hybrid screening system. J. Antibiot. 51: 936-944
- Kim, M. S., H. J. Kwon, Y. M. Lee, J. H. Baek, J. E. Jang, S. W. Lee, E. J. Moon, H. S. Kim, S. K. Lee, H. Y. Chung, C. W. Kim, and K. W. Kim. 2001. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat. Med. 7: 437-443
- Kim, M. S., M. W. Son, W. B. Kim, Y. I. Park, and A. Moon. 2001. Apicidin, an inhibitor of histone deacetylase, prevents H-ras-induced invasive phenotype. Cancer Lett. 157: 23- 30
- Kuo, M. H. and C. D. Allis. 1998. Roles of histone acetyltransferases and deacetylases in gene regulation. BioEssays 20: 615-626
- Kwon, H. J., M. S. Kim, M. J. Kim, H. Nakajima, and K. W. Kim. 2002. Histone deacetylase inhibitor FK228 inhibits tumor angiogenesis. 2002. Int. J. Cancer 97: 290-296
- Kwon, H. J., T. Owa, C. A. Hassig, J. Shimada, and S. L. Schreiber. 1998. Depudecin induces morphological reversion of transformed fibroblasts via the inhibition of histone deacetylase. Proc. Natl. Acad. Sci. USA 95: 3356-3361.
- Laherty, C. D., W. M. Yang, J. M. Sun, J. R. Davie, E. Seto, and R. N. Eisenman. 1997. Histone deacetylases associated with the mSin3 corepressor mediate Mad transcriptional repression. Cell 89: 349-356
- Luo, J., F. Su, E. Chen, A. Shiloh, and W. Gu. 2000. Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature 408: 377-381
- Matchmaker LexA two-hybrid system user manual, Clontech, U.S.A
- Mazumdar, A., R. A. Wang, S. K. Mishra, L. Adam, R. Bagheri-Yarmand, M. Mandal, R. K. Vadlamudi, and R. Kumar. 2001. Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor. Nat. Cell Biol. 3: 30-37 https://doi.org/10.1038/35050532
- Nakajima, H., Y. B. Kim, H. Terano, M. Yoshida, and S. Horinouchi. 1998. FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor. Exp. Cell Res. 241: 126-133
- Nam, J. Y., K. H. Son, H. K. Kim, N. Y. Han, S. U. Kim, J. D. Choi, and B. M. Kwon. 2000. Sclerotiorin and isochromophilone IV: Inhibitors of Grb2-Shc interaction, isolated from Penicillium multicolor F1753. J. Microbiol. Biotechnol. 10: 544-546
- Nawa, A., K. Nishimori, P. Lin, Y. Maki, K. Moue, H. Sawada, Y. Toh, K. Fumitaka, and G. L. Nicolson. 2000. Tumor metastasis-associated human MTA1 gene: Its deduced protein sequence, localization, and association with breast cancer cell proliferation using antisense phosphorothioate oligonucleotides. J. Cell Biochem. 79: 202-212
- Park, Y. H., E. K. Moon, Y. K. Shin, and M. A. Bae. 2000. Antitumor activity of Paecilomyces japonica is mediated by apoptotic cell death. J. Microbiol. Biotechnol. 10: 16-20
- Saito, A., T. Yamashita, Y. Mariko, Y. Nosaka,, K. Tsuchiya, T. Ando, et al. 1999. A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors. Proc. Natl. Acad. Sci. USA 96: 4592-4597
- Schmidt, C. R. and S. L. Schreiber. 1999. Molecular association between ATR and two components of the nucleosome remodeling and deacetylating complex, HDAC2 and CHD4. Biochemistry 38: 14711-14717 https://doi.org/10.1021/bi991614n
- Toh, Y., S. D. Pencil, and G. L. Nicolson. 1994. A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. J. Biol. Chem. 16: 22958-22963
- Toh, Y., S. Kuninaka, K. Endo, T. Oshiro, Y. Ikeda, H. Nakashima, H. Baba, S. Kohnoe, T. Okamura, G. L. Nicolson, and K. Sugimachi. 2000. Molecular analysis of a candidate metastasis-associated gene, MTA1: Possible interaction with histone deacetylase 1. J. Exp. Clin. Cancer Res. 19: 105-111
- Tong, J. K., C. A. Hassig, G. R. Schnitzier, R. E. Kingston, and S. L. Schreiber. 1998. Chromatin deacetylation by an ATP-dependent nucleosome remodeling complex. Nature 395: 917-921
- Verdel, A. and S. Khochbin. 1999. Identification of a new family of higher eukaryotic histone deacetylases. J. Biol. Chem. 274: 2440-2445
- Wang, Y., W. Devereux, T. M. Stewart, and R. A. Casero, Jr. 1999. Cloning and characterization of human polyaminemodulated factor-1, a transcriptional cofactor that regulates the transcription of the spermidine/spermine N1-acetyltransferase gene. J. Biol. Chem. 274: 22095-22101
- Wolffe, A. P. 1996. Histone deacetylase: A regulator of transcription. Science 272: 371-372
- Yang, W. M., Y. L. Yao, J. M. Sun, J. R. Davie, and E. Seto. 1997. Isolation and characterization of cDNAs corresponding to an additional member of the human histone deacetylase gene family. J. Biol. Chem. 272: 28001-28007
- Yang, X., A. T. Ferguson, S. J. Nass, D. L. Phillips, K. A. Butash, S. M. Wang, J. G. Herman, and N. E. Davidson. 2000. Transcriptional activation of estrogen receptor a in human breast cancer cells by histone deacetylase inhibition. Cancer Res. 60: 6890-6894
- Yoshida, M., M. Kijima, M. Akita, and T. Beppu. 1990. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 265: 17174-17179
- Yoshida, M., S. Horinouchi, and T. Beppu. 1995. Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function. BioEssays 17: 423-430